Paeds Vivas · respiratory-sleep-and-airway
Congenital lung and airway malformations — structured oral (viva)
Branching structured oral on a large antenatally detected lung lesion progressing toward hydrops, testing antenatal risk stratification, fetal therapy, neonatal stabilisation and definitive surgery.
On this page
Study tools
Target exams
Branch 1 — Antenatal risk stratification
Examiner: "You are the fetal-medicine registrar. How do you decide how worried to be about this lesion?" Candidate: The raw size matters less than its physiological effect, so I focus on the mediastinal shift, the compression of the heart and great veins, and any early signs of hydrops such as skin oedema, ascites or a pericardial effusion. I would quantify the lesion using the CPAM volume ratio, a size index that predicts the risk of hydrops and directs how intensively the pregnancy is monitored, and I would follow it with serial ultrasound. A large solid microcystic lesion with a rising volume ratio and early hydrops marks this fetus as high risk. [1] [2]
References4ShowHide
- [1]Pederiva F, Rothenberg SS, Hall N, et al Congenital lung malformations. Nat Rev Dis Primers, 2023.PMID 37919294
- [2]Kontopoulos E, Quintero LF, Quintero Kontopoulos A, et al Mathematical reappraisal of the congenital cystic adenomatoid malformation volume ratio. J Matern Fetal Neonatal Med, 2026.PMID 42010266
- [3]Peranteau WH, Boelig MM, Khalek N, et al Effect of single and multiple courses of maternal betamethasone on prenatal congenital lung lesion growth and fetal survival. J Pediatr Surg, 2016.PMID 26526208
- [4]Muntean A, Marsland L, Sikdar O, et al Neonatal Surgery for Congenital Lung Malformations: Indications, Outcomes and Association With Malignancy. J Pediatr Surg, 2025.PMID 40031114